Efficacy of voriconazole in a murine model of invasive paecilomycosis

International Journal of Antimicrobial Agents

Volumn 35, Issue 4, 2010, Pages 362-365

  Rodríguez, M Mar ^a   Pastor, F Javier ^a   Serena, Carolina ^a   Guarro, Josep ^a  

^a FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

Author keywords

Amphotericin B; Mice; Paecilomyces lilacinus; Voriconazole

Indexed keywords

AMPHOTERICIN B; CEFTAZIDIME; CYCLOPHOSPHAMIDE; FLUOROURACIL; FUNGIZONA; UNCLASSIFIED DRUG; VORICONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG CLEARANCE; DRUG EFFICACY; FUNGAL STRAIN; FUNGAL VIRULENCE; GRAPEFRUIT JUICE; IMMUNE DEFICIENCY; KIDNEY; LIVER; MALE; MOUSE; MYCOSIS; NONHUMAN; PAECILOMYCES LILACINUS; PAECILOMYCOSIS; PRIORITY JOURNAL; SPLEEN; SURVIVAL RATE;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; CITRUS PARADISI; COLONY COUNT, MICROBIAL; DIET; IMMUNOCOMPROMISED HOST; KIDNEY; LIVER; MALE; MICE; MYCOSES; PAECILOMYCES; PYRIMIDINES; SPLEEN; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TRIAZOLES;

EID: 77049119904     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.11.018     Document Type: Article

References (37)

1. Pastor F.J., and Guarro J. Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin Microbiol Infect 12 (2006) 948-960
2. Carey J., D'Amico R., Sutton D.A., and Rinaldi M.G. Paecilomyces lilacinus vaginitis in an immuno-competent patient. Emerg Infect Dis 9 (2003) 1155-1158
3. Castro L.G.M., Salebian A., and Sotto M.N. Hyalohyphomycosis by Paecilomyces lilacinus in a renal transplant recipient and a review of human Paecilomyces species infections. J Med Vet Mycol 28 (1990) 15-26
4. Itin P.H., Frei R., Lautenschlager S., Buechner S.A., Surber C., Gratwohl A., et al. Cutaneous manifestations of Paecilomyces lilacinus infection induced by a contaminated skin lotion in patients who are severely immunosuppressed. J Am Acad Dermatol 39 (1998) 401-409
5. Gutierrez-Rodero F., Morganon M., Ortiz de la Tabla V., Mayoll M.J., and Martin C. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus in an immunocompetent host successfully treated with itraconazole: case report and review. Eur J Clin Microbiol Infect Dis 18 (1999) 814-818
6. Orth B., Frei R., Itin P.H., Rinaldi M.G., Speck B., Gratwohl A., et al. Outbreak of invasive mycoses caused by Paecilomyces lilacinus from a contaminated skin lotion. Ann Intern Med 125 (1996) 799-806
7. Minogue M.J., Playfair T.J., Gregory-Roberts J.C., and Robinson L.P. Cure of Paecilomyces endophthalmitis with multiple intravitreal injections of amphotericin B. Case report. Arch Ophthalmol 107 (1989) 1281
8. D'Mellow G., Hirst L.W., Whitby M., Nimmo G., and Stallard K. Intralenticular infections. Ophthalmology 98 (1991) 1376-1378
9. Hirst L.W., Sebban A., Whitby M., Nimmo G., and Stallard K. Non-traumatic mycotic keratitis. Eye (Lond) 6 (1992) 391-395
10. Domniz Y., Lawless M., Sutton G.L., Rogers C.M., and Meagher L.J. Successful treatment of Paecilomyces lilacinus endophthalmitis after foreign body trauma to the cornea. Cornea 20 (2001) 109-111
11. O'Sullivan M.V.N., Withby M., Hirst L.W., Apel A.J.G., and Ellis D. Outcome of Paecilomyces species ophthalmic infections treated with systemic voriconazole. Program and Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 14-17 September 2003, Chicago, IL (2003), ASM Press, Washington, DC 448 [Abstract M-972]
12. Anderson K.L., Mitra S., Salouti R., Pham T.A., and Taylor H.R. Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hair. Cornea 23 (2004) 516-521
13. Okhravi N., Dart J.K., Towler H.M., and Lightman S. Paecilomyces lilacinus endophthalmitis with secondary keratitis. Arch Ophthalmol 115 (1997) 1320-1324
14. Pintor E., Martin M., Garcia P., and Gonzalez M. Endophthalmitis due to Paecilomyces lilacinus after non-surgical penetrating trauma [in Spanish]. Enferm Infecc Microbiol Clin 19 (2001) 374-378
15. Hecker M.S., Weinberg J.M., Bagheri B., Tangoren I.A., Rudikoff D., Bottone E., et al. Cutaneous Paecilomyces lilacinus infection: report of two novel cases. J Am Acad Dermatol 37 (1997) 270-277
16. Gottlieb T., and Atkins B.L. Case report. Successful treatment of cutaneous Paecilomyces lilacinus infection with oral itraconazole in an immune competent host. Mycoses 44 (2001) 513-515
17. Hall V.C., Goyal S., Davis M.D.P., and Walsh J.S. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus: report of three cases and review of the literature. Int J Dermatol 43 (2004) 648-653
18. Yuan X., Wilhelmus K.R., Matoba A.Y., Alexandrakis G., Miller D., and Huang A.J. Pathogenesis and outcome of Paecilomyces keratitis. Am J Ophtalmol 147 (2009) 691-696
19. Liu K., Howell D.N., Perfect J.R., and Schell W.A. Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology. Am J Clin Pathol 109 (1998) 45-54
20. Clark N.M. Paecilomyces lilacinus infection in a heart transplant recipient and successful treatment with terbinafine. Clin Infect Dis 28 (1999) 1169-1170
21. Jade K.B., Lyons M.F., and Gnann J.W. Paecilomyces lilacinus cellulitis in an immunocompromised patient. Arch Dermatol 122 (1986) 1169-1170
22. Murciano A., Domer J., and Cohen I. Paecilomyces lilacinus infection in an immunocompromised patient. J La State Med Soc 142 (1990) 35-37
23. Legeais J.M., Blanc V., Basset D., D'Hermies F., Harrabi S., Frau E., et al. Severe keratomycosis. Diagnosis and treatment. J Fr Ophtalmol 17 (1994) 568-573 [in French]
24. Scott I.U., Flynn H.W., Miller D., Speights J.W., Snip R.C., and Brod R.D. Exogenous endophthalmitis caused by amphotericin B-resistant Paecilomyces lilacinus: treatment options and visual outcomes. Arch Ophthalmol 119 (2001) 916-919
25. Martin C.A., Roberts S., and Greenberg R.N. Voriconazole treatment of disseminated Paecilomyces infection in a patient with acquired immunodeficiency syndrome. Clin Infect Dis 35 (2002) 78-81
26. Aguilar C., Pujol I., Sala J., and Guarro J. Antifungal susceptibilities of Paecilomyces species. Antimicrob Agents Chemother 42 (1998) 1601-1604
27. Espinel-Ingroff A. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J Clin Microbiol 39 (2001) 954-958
28. Espinel-Ingroff A., Chaturvedi V., Fothergill A., and Rinaldi M.G. Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study. J Clin Microbiol 40 (2002) 3776-3781
29. Rodríguez M.M., Pastor F.J., Serena C., and Guarro J. Posaconazole efficacy in a murine disseminated infection caused by Paecilomyces lilacinus. J Antimicrob Chemother 63 (2009) 361-364
30. Van Schooneveld T., Freifeld A., Lesiak B., Kalil A., Sutton D.A., and Iwen P.C. Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature. Transpl Infect Dis 10 (2007) 117-122
31. de Hoog G.S., Guarro J., Gené J., and Figueras M.J. Atlas of clinical fungi. 2nd. ed. (2000), Centraalbureau voor Schimmelcultures/Universitat Rovira i Virgili, Utrecht, The Netherlands/Reus, Spain
32. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard. 2nd ed. Document M38-A2. Wayne, PA: NCCLS; 2008.
33. Sugar A.M., and Liu X. Efficacy of voriconazole in treatment of murine pulmonary blastomycosis. Antimicrob Agents Chemother 45 (2001) 601-604
34. Graybill J.R., Najvar L.K., Gonzalez G.M., Hernández S., and Bocanegra R. Improving the mouse model for studying the efficacy of voriconazole. J Antimicrob Chemother 51 (2003) 1373-1376
35. Rodríguez M.M., Calvo E., Serena C., Mariné M., Pastor F.J., and Guarro J. Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans. Antimicrob Agents Chemother 53 (2009) 2153-2155
36. Pujol I., Aguilar C., Ortoneda M., Pastor J., Mayayo E., and Guarro J. Experimental pathogenicity of three opportunistic Paecilomyces species in a murine model. J Mycol Med 12 (2002) 1286-1289
37. Garbino J., Ondrusova A., Baligvo E., Lew D., Bouchuiguir-Wafa K., and Rohner P. Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole. Scand J Infect Dis 34 (2002) 701-703